Carlos Cruchaga

{{Infobox scientist | name = | native_name = | native_name_lang = | image = | image_size = | caption = | birth_date = | birth_place = | death_date = | death_place = | death_cause = | citizenship = | nationality = Spanish | fields = Neurogenomics | workplaces = Washington University in St. Louis
McDonnell Genome Institute | doctoral_advisor = Juan Jose Martinez Irujo | alma_mater = University of Navarra (BS, PHD) | known_for = Identification and characterization of TREM2 | awards = | spouse = | partner = | children = | website = [https://cruchagalab.wustl.edu/ Lab website] }} Carlos Cruchaga is a human genomicist with expertise in multi-omics, informatics, and neurodegeneration, with a focus on Alzheimer's disease and Parkinson's disease. He is a Professor of Psychiatry, Neurology and Genetics and Washington University School of Medicine. He is founding director of the Neurogenomics and Informatic (NGI) center at Washington University School of Medicine.

His lab uses deep molecular profiling of human samples relevant to brain and neurodegenerative diseases. He is best known for using endophenotypes and biomarkers as quantitative traits for genetics studies, which led to the identification of novel variants associated with Alzheimer's Disease risk, onset and progression. Provided by Wikipedia